Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

713
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
713
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.2K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.2K
Depression: Overview01:18

Depression: Overview

683
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
683
Drug Therapy01:28

Drug Therapy

205
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
205
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

375
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
375
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

1.2K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of artificial intelligence in addiction medicine.

Journal of addictive diseases·2025
Same author

American Civil War medical practice, the post-bellum opium crisis and modern comparisons.

History of psychiatry·2020
Same author

Prospective Study of Brain Wave Changes Associated With Cranial Electrotherapy Stimulation.

The primary care companion for CNS disorders·2018
Same author

Alcohol Biomarkers Associated with Obstructive Sleep Apnea.

Substance use & misuse·2017
Same author

The Reasons for Living Scale-Military Version: Assessing Protective Factors Against Suicide in a Military Sample.

Military medicine·2017
Same author

Efficacy of transcranial magnetic stimulation for treatment resistant depression among active duty service members.

General hospital psychiatry·2016

Related Experiment Video

Updated: Dec 30, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

461

Nutraceutical Augmentation Strategies for Depression: A Narrative Review.

R Gregory Lande

    The Journal of the American Osteopathic Association
    |January 28, 2020
    PubMed
    Summary
    This summary is machine-generated.

    Nutraceuticals like S-adenosylmethionine and omega-3 fatty acids show promise for augmenting depression treatment when standard therapies fall short. These supplements may help patients achieve clinical remission.

    More Related Videos

    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
    04:29

    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

    Published on: January 7, 2019

    29.4K
    Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
    07:58

    Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

    Published on: February 24, 2023

    756

    Related Experiment Videos

    Last Updated: Dec 30, 2025

    Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
    08:15

    Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

    Published on: June 6, 2025

    461
    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
    04:29

    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

    Published on: January 7, 2019

    29.4K
    Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
    07:58

    Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

    Published on: February 24, 2023

    756

    Area of Science:

    • Psychiatry
    • Nutritional Neuroscience
    • Pharmacology

    Background:

    • Depression is a prevalent psychiatric disorder with suboptimal treatment outcomes.
    • Antidepressant pharmacotherapy frequently fails to achieve complete remission.
    • Augmentation strategies are crucial for improving depression management.

    Purpose of the Study:

    • To evaluate the safety, tolerability, and efficacy of nutraceuticals as augmentation therapy for depression.
    • To identify evidence-based nutraceuticals for managing depressive symptoms.

    Main Methods:

    • Systematic reviews and clinical practice guidelines focused on nutraceuticals for depression were analyzed.
    • Commonly studied nutraceutical augmentation strategies were identified.

    Main Results:

    • S-adenosylmethionine (SAMe), l-methylfolate, omega-3 fatty acids, and hydroxyvitamin D demonstrated sufficient evidence for clinical consideration.
    • These nutraceuticals are supported for use in a stepped care approach for depression.

    Conclusions:

    • Clinical remission is the primary goal in treating depression.
    • Nutraceuticals can be a valuable component of a comprehensive treatment strategy to achieve remission.